PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
XHE vs. ARKG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


XHEARKG
YTD Return7.98%-21.82%
1Y Return25.54%-1.19%
3Y Return (Ann)-10.27%-29.49%
5Y Return (Ann)1.82%-3.32%
10Y Return (Ann)9.09%3.44%
Sharpe Ratio1.590.18
Sortino Ratio2.350.58
Omega Ratio1.281.06
Calmar Ratio0.700.09
Martin Ratio10.270.34
Ulcer Index3.12%22.10%
Daily Std Dev20.10%40.94%
Max Drawdown-49.92%-80.10%
Current Drawdown-31.71%-77.05%

Correlation

-0.50.00.51.00.7

The correlation between XHE and ARKG is 0.72, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

XHE vs. ARKG - Performance Comparison

In the year-to-date period, XHE achieves a 7.98% return, which is significantly higher than ARKG's -21.82% return. Over the past 10 years, XHE has outperformed ARKG with an annualized return of 9.09%, while ARKG has yielded a comparatively lower 3.44% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%JuneJulyAugustSeptemberOctoberNovember
3.74%
-3.24%
XHE
ARKG

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


XHE vs. ARKG - Expense Ratio Comparison

XHE has a 0.35% expense ratio, which is lower than ARKG's 0.75% expense ratio.


ARKG
ARK Genomic Revolution Multi-Sector ETF
Expense ratio chart for ARKG: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%
Expense ratio chart for XHE: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%

Risk-Adjusted Performance

XHE vs. ARKG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Health Care Equipment ETF (XHE) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XHE
Sharpe ratio
The chart of Sharpe ratio for XHE, currently valued at 1.59, compared to the broader market-2.000.002.004.001.59
Sortino ratio
The chart of Sortino ratio for XHE, currently valued at 2.35, compared to the broader market-2.000.002.004.006.008.0010.0012.002.35
Omega ratio
The chart of Omega ratio for XHE, currently valued at 1.28, compared to the broader market1.001.502.002.503.001.28
Calmar ratio
The chart of Calmar ratio for XHE, currently valued at 0.70, compared to the broader market0.005.0010.0015.000.70
Martin ratio
The chart of Martin ratio for XHE, currently valued at 10.27, compared to the broader market0.0020.0040.0060.0080.00100.0010.27
ARKG
Sharpe ratio
The chart of Sharpe ratio for ARKG, currently valued at 0.18, compared to the broader market-2.000.002.004.000.18
Sortino ratio
The chart of Sortino ratio for ARKG, currently valued at 0.58, compared to the broader market-2.000.002.004.006.008.0010.0012.000.58
Omega ratio
The chart of Omega ratio for ARKG, currently valued at 1.06, compared to the broader market1.001.502.002.503.001.06
Calmar ratio
The chart of Calmar ratio for ARKG, currently valued at 0.09, compared to the broader market0.005.0010.0015.000.09
Martin ratio
The chart of Martin ratio for ARKG, currently valued at 0.34, compared to the broader market0.0020.0040.0060.0080.00100.000.34

XHE vs. ARKG - Sharpe Ratio Comparison

The current XHE Sharpe Ratio is 1.59, which is higher than the ARKG Sharpe Ratio of 0.18. The chart below compares the historical Sharpe Ratios of XHE and ARKG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.59
0.18
XHE
ARKG

Dividends

XHE vs. ARKG - Dividend Comparison

XHE's dividend yield for the trailing twelve months is around 0.04%, while ARKG has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
XHE
SPDR S&P Health Care Equipment ETF
0.04%0.03%0.04%0.00%0.00%0.05%0.09%0.78%0.17%7.22%1.83%0.19%
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%0.00%0.00%0.00%0.00%

Drawdowns

XHE vs. ARKG - Drawdown Comparison

The maximum XHE drawdown since its inception was -49.92%, smaller than the maximum ARKG drawdown of -80.10%. Use the drawdown chart below to compare losses from any high point for XHE and ARKG. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%JuneJulyAugustSeptemberOctoberNovember
-31.71%
-77.05%
XHE
ARKG

Volatility

XHE vs. ARKG - Volatility Comparison

The current volatility for SPDR S&P Health Care Equipment ETF (XHE) is 5.21%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 11.08%. This indicates that XHE experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%JuneJulyAugustSeptemberOctoberNovember
5.21%
11.08%
XHE
ARKG